Boston Scientific Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Boston Scientific Corporation on October 22, 2025. The filing addresses a corporate governance matter regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to Item 5.02 and contains no financial performance data.
Material Changes
The material change reported is the announcement that John E. Sununu will not stand for re-election as a director at the 2026 Annual Meeting of Stockholders. Mr. Sununu has served on the Board since April 2009 and currently chairs the Nominating and Governance Committee and serves on the Audit Committee. He will continue to serve in these roles until the 2026 Annual Meeting. The filing explicitly states this decision is not the result of any disagreement with the Company.
Guidance, Outlook, and Risks
The Board and Nominating and Governance Committee will evaluate whether to add new directors following Mr. Sununu's departure. No financial guidance, outlook, or specific risk factors were disclosed in this filing.
Key Facts for Investors
- John E. Sununu will not seek re-election at the 2026 Annual Meeting.
- Mr. Sununu remains a director and committee member until the 2026 Annual Meeting.
- The departure is voluntary and not due to any disagreement with the Company.
- The Board will assess the need to appoint a replacement director.